Literature DB >> 8883932

Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains.

P J Norris1, R L Faull, P C Emson.   

Abstract

Neuronal nitric oxide synthase (nNOS) mRNA levels and NADPH diaphorase (NADPH-d) staining were compared in the frontal cortex, visual cortex and hippocampus (dentate gyrus and CA subfields of Ammon's horn) of five Alzheimer's disease (AD) and six control brains. The cellular abundance of nNOS mRNA was quantified by in-situ hybridisation using 35S-labelled antisense oligonucleotides complementary to the human nNOS sequence. Although the mean level of nNOS expression was decreased in all three regions in AD cases as compared to controls, it did not reach significance. Neurones positively labelled for nNOS mRNA and neurones positive for NADPH-d histochemistry displayed similar distribution in control and AD cases. In AD brains the density of neurones having detectable levels of nNOS mRNA was significantly decreased in the white matter underlying the frontal cortex (P < 0.05) but not in the frontal cortex gray matter; no change was observed in the gray or white matter of the visual cortex in AD. The number of cells expressing detectable levels of nNOS mRNA in the hippocampus was also significantly decreased (P < 0.05) in AD. The density of NADPH-d-positive cells was not significantly decreased in the gray or white matter of the frontal or visual cortices in AD compared to controls; however, the number of NADPH-d-positive cells was significantly decreased in the hippocampus (P < 0.01). These data indicate that although the cellular abundance of nNOS mRNA is not significantly decreased in these three regions in AD, there is a significant decrease in the number of cells expressing detectable levels of nNOS mRNA in the white matter underlying the frontal cortex and in the dentate gyrus and CA subfields of the hippocampus in AD. Furthermore, there was also a significant decrease in the number of NADPH-d-positive cells in the dentate gyrus and CA subfields of the hippocampus in AD as compared to controls. These results suggest specific populations of nNOS/NADPH-d cells in the white matter underlying the frontal cortex and in the hippocampus are vulnerable in AD. The implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883932     DOI: 10.1016/0169-328x(96)00064-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  11 in total

Review 1.  Populations of subplate and interstitial neurons in fetal and adult human telencephalon.

Authors:  Miloš Judaš; Goran Sedmak; Mihovil Pletikos; Nataša Jovanov-Milošević
Journal:  J Anat       Date:  2010-10       Impact factor: 2.610

Review 2.  The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention.

Authors:  J A Molina; F J Jiménez-Jiménez; M Ortí-Pareja; J A Navarro
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

3.  Facilitation of corticostriatal transmission following pharmacological inhibition of striatal phosphodiesterase 10A: role of nitric oxide-soluble guanylyl cyclase-cGMP signaling pathways.

Authors:  Fernando E Padovan-Neto; Stephen Sammut; Shreaya Chakroborty; Alexander M Dec; Sarah Threlfell; Peter W Campbell; Vishnu Mudrakola; John F Harms; Christopher J Schmidt; Anthony R West
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

Review 4.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

5.  Metallothionein-3 and neuronal nitric oxide synthase levels in brains from the Tg2576 mouse model of Alzheimer's disease.

Authors:  Bruce L Martin; Abigail M Tokheim; Patrick T McCarthy; Brendan S Doms; Andrew A Davis; Ian M Armitage
Journal:  Mol Cell Biochem       Date:  2006-02       Impact factor: 3.396

6.  The effect of cauda equina constriction on nitric oxide synthase activity.

Authors:  Nadezda Lukácová; Jozef Kafka; Dása Cízková; Martin Marsala; Jozef Marsala
Journal:  Neurochem Res       Date:  2004-02       Impact factor: 3.996

Review 7.  Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide.

Authors:  Rachelle Balez; Lezanne Ooi
Journal:  Oxid Med Cell Longev       Date:  2015-11-30       Impact factor: 6.543

8.  Association of cerebrovascular dysfunction with the development of Alzheimer's disease-like pathology in OXYS rats.

Authors:  Natalia A Stefanova; Kseniya Yi Maksimova; Ekaterina A Rudnitskaya; Natalia A Muraleva; Nataliya G Kolosova
Journal:  BMC Genomics       Date:  2018-02-09       Impact factor: 3.969

Review 9.  Memory Enhancers for Alzheimer's Dementia: Focus on cGMP.

Authors:  Ernesto Fedele; Roberta Ricciarelli
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-13

10.  Cell-autonomous role of Presenilin in age-dependent survival of cortical interneurons.

Authors:  Jongkyun Kang; Jie Shen
Journal:  Mol Neurodegener       Date:  2020-12-10       Impact factor: 18.879

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.